“Omicron got mutations that changed the protein on the surface, and the antibodies that developed against previous strains began to recognize this new strain much worse, which means that they do not attach well to the virus, which means that they do not well prevent the virus from entering the body human”, – said Albert Rizvanov, director of the Scientific and Clinical Center for Precision and Regenerative Medicine of the Institute of Fundamental Medicine and Biology of KFU.
Such a burning mixture causes concern among experts, but the new strain has not yet become widespread, and therefore there is no reason for strong feelings. At the same time, scientists note that in the case of the Indian hybrid, it is the nasal vaccine that may be more useful – it will protect the human mucosa and prevent the infection from entering the body.